EP Patent

EP3095466A1 — Pharmaceutical formulations with improved solubility and stability

Assigned to Abdi Ibrahim Ilac Sanayi Ve Ticaret AS · Expires 2016-11-23 · 9y expired

What this patent protects

The present invention relates to the pharmaceutical formulations to be used in the symptomatic treatment of respiratory tract infections such as cold and flu.

USPTO Abstract

The present invention relates to the pharmaceutical formulations to be used in the symptomatic treatment of respiratory tract infections such as cold and flu.

Drugs covered by this patent

Patent Metadata

Patent number
EP3095466A1
Jurisdiction
EP
Classification
—
Expires
2016-11-23
Drug substance claim
No
Drug product claim
No
Assignee
Abdi Ibrahim Ilac Sanayi Ve Ticaret AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.